Fidelity Investments
IBB icon

Fidelity Investments’s iShares Biotechnology ETF IBB Stock Holding History

Fidelity Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,000
Closed -$1.18M – 2767
2014
Q1 		$1.18M Sell
15,000
-11,400
-43% -$950K ﹤0.01% 2454
2013
Q4 		$2M Buy
+26,400
New +$1.87M ﹤0.01% 2346

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Fidelity Investments's IBB Position: Q2 2026 in Review

Fidelity Investments increased its iShares Biotechnology ETF (IBB) stake by 1.1% in Q2 2026, buying an estimated $35.4K and bringing the position to 18,641 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

Fidelity Investments first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.4M in Q4 2013. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Fidelity Investments held 18,641 shares of iShares Biotechnology ETF worth $3.56M as of Q2 2026.
  • Fidelity Investments bought 206 iShares Biotechnology ETF shares in Q2 2026, an estimated $35.4K.
  • iShares Biotechnology ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2551 holding.
  • Fidelity Investments first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Fidelity Investments's iShares Biotechnology ETF position peaked at $42.4M in Q4 2013.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.